Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers.
Target Price
The average target price of DRIO is 18 and suggests 51% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell